atenolol has been researched along with Keratoconjunctivitis Sicca in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Keratoconjunctivitis Sicca: Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barsotti, G | 1 |
| Vezzosi, T | 1 |
1 other study available for atenolol and Keratoconjunctivitis Sicca
| Article | Year |
|---|---|
Keratoconjunctivitis sicca exacerbation in a dog treated with systemic atenolol.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Dog Diseases; Dogs; Keratoconjunctivitis | 2016 |